All Studies Meta Analysis

Severe COVID-19 patients have severe vitamin D deficiency in Northeast Mexico

Rodríguez-Vidales et al., Nutrición Hospitalaria, doi:10.20960/nh.03731

Feb 2022

Post
Facebook

Source PDF All Studies Meta AnalysisMeta

Download Image

Vitamin D for COVID-19

8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.

Lower risk for mortality, ICU, hospitalization, progression, recovery, cases, and viral clearance.

No treatment is 100% effective. Protocols combine treatments.

5,100+ studies for 112 treatments. c19early.org

Retrospective 181 diagnostic center patients and 116 ICU patients in Mexico, showing higher risk of severity with vitamin D levels <10ng/mL.

This is the 123rd of 211 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 248,027,826 vigintillion).

Important missing comments or errors? Let us know.

risk of severe case, 38.9% lower, RR 0.61, p = 0.05, high D levels (≥10ng/mL) 89 of 265 (33.6%), low D levels (<10ng/mL) 27 of 32 (84.4%), NNT 2.0, adjusted per study, inverted to make RR<1 favor high D levels (≥10ng/mL), odds ratio converted to relative risk, multivariable.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Rodríguez-Vidales et al., 24 Feb 2022, retrospective, Mexico, peer-reviewed, 8 authors, study period March 2020 - September 2020.

This Paper Vitamin D All

Severe COVID-19 patients have severe vitamin D deficiency in Northeast Mexico

Manuel Enrique De La O-Cavazos, Edgar Paolo Rodríguez Vidales, Denise Garza Carrillo, Ana María Salinas Martínez, Olivia Abigail Robles Rodríguez, Roberto Montes De Oca Luna, Consuelo Treviño Garza, Alma Rosa Marroquín Escamilla

Nutrición Hospitalaria, doi:10.20960/nh.03731

Objective: the association between vitamin D and COVID-19 severity is not consistent. We compared prevalences and analyzed the association between vitamin D deficiency and COVID-19 severity in Northeast Mexico. Methods : this was a cross-sectional study with individuals consecutively included at a referral diagnostic center during March-September 2020 (n = 181). Concurrently, every patient admitted to intensive care was also consecutively included (n = 116). Serum 25(OH)D < 20 ng/mL was considered vitamin D deficiency. Descriptive, ANOVA, and multivariate ordinal regression analyses were performed. Results: vitamin D deficiency prevalence was 63.8 % (95 % CI, 54.7, 72.0) in severe COVID-19; 25.6 % (95 % CI, 17.4, 36.0) in mild COVID-19; and 42.4 % (95 % CI, 33.2, 52.3) in non-diseased individuals. Vitamin D deficiency increased 5 times the odds of severe COVID-19 (95 % CI, 1.1, 24.3), independently of sex, age, body mass index, and inflammatory markers. Conclusions: this study is the first report of vitamin D deficiency in Northeast Mexico. Vitamin D deficiency was associated with COVID-19 severity.

References

Adami, Giollo, Fassio, Benini, Bertoldo et al., Vitamin D and disease severity in coronavirus disease 19 (COVID-19), Reumatismo, doi:10.4081/reumatismo.2020.1333

Alsafar, Grant, Hijazi, Uddin, Alkaabi et al., COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents, Nutrients, doi:10.3390/nu13051714

Braun, Chang, Mahadevappa, Gibbons, Liu et al., Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill, Crit Care Med, doi:10.1097/CCM.0b013e318206ccdf

Butt, Kurdowska, Allen, Acute Lung Injury: A Clinical and Molecular Review, Arch Pathol Lab Med 2016r, doi:10.5858/arpa.2015-0519-RA

Cashman, Dowling, Škrabáková, Gonzalez-Gross, Valtueña et al., Vitamin D deficiency in Europe: pandemic?12, Am J Clin Nutr, doi:10.3945/ajcn.115.120873

Cereda, Bogliolo, Klersy, Lobascio, Masi et al., Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital, Clin Nutr, doi:10.1016/j.clnu.2020.10.055

D'avolio, Avataneo, Manca, Cusato, Nicolò et al., 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2, Nutrients, doi:10.3390/nu12051359

De Haan, Groeneveld, De Geus, Egal, Struijs, None

Dusso, Sigaroodi, Bashash, Fateh, Abolghasemi, Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation, Kidney Int Suppl, doi:10.1038/kisup.2011.30

Elizondo-Montemayor, Castillo, Rodríguez-López, Villarreal-Calderón, Gómez-Carmona et al., Seasonal Variation in Vitamin D in Association with Age, Inflammatory Cytokines, Anthropometric Parameters, and Lifestyle Factors in Older Adults, Mediators Inflamm, doi:10.1155/2017/5719461

Gois, Ferreira, Olenski, Seguro, Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor?, Nutrients, doi:10.3390/nu9070651

Hernández, Nan, Fernandez-Ayala, García-Unzueta, Hernández-Hernández et al., Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection, J Clin Endocrinol Metab, doi:10.1210/clinem/dgaa733

Hughes, Beasley, Pulmonary Manifestations of Acute Lung Injury: More Than Just Diffuse Alveolar Damage, Arch Pathol Lab Med, doi:10.5858/arpa.2016-0342-RA

Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res, doi:10.21203/rs.3.rs-21211/v1

Jain, Chaurasia, Sengar, Singh, Mahor et al., Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers, Scientific Reports, doi:10.1038/s41598-020-77093-z

Kazemi, Mohammadi, Aghababaee, Golzarand, Clark et al., Association of Vitamin D Status with SARS-CoV-2 Infection or COVID-19 Severity: A Systematic Review and Meta-analysis, Advances in Nutrition

Maghbooli, Sahraian, Ebrahimi, Pazoki, Kafan et al., Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection, PLoS One, doi:10.1371/journal.pone.0239799

Mccartney, Shea, Faul, Healy, Byrne et al., Vitamin D and SARS-CoV-2 infection-evolution of evidence supporting clinical practice and policy development, Ir J Med Sci, doi:10.1007/s11845-020-02427-9

Moan, Porojnicu, Dahlback, Setlow, Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure, Proc Natl Acad Sci U S A, doi:10.1073/pnas.0710615105

Ohaegbulam, Swalih, Patel, Smith, Perrin, None

Panagiotou, Tee, Ihsan, Athar, Marchitelli et al., Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity, Clin Endocrinol (Oxf), doi:10.1101/2020.06.21.20136903

Smet, Smet, Herroelen, Gryspeerdt, Martens, Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality, Am J Clin Pathol, doi:10.1093/ajcp/aqaa252

Szeto, Zucker, Lasota, Rubin, Walker et al., Vitamin D Status and COVID-19 Clinical Outcomes in Hospitalized Patients, Endocr Res, doi:10.1080/07435800.2020.1867162

White, Vitamin D metabolism and signaling in the immune system, Rev Endocr Metab Disord, doi:10.1007/s11154-011-9195-z

Wu, Mcgoogan, Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention, JAMA, doi:10.1001/jama.2020.2648

Ye, Tang, Liao, Shaw, Deng et al., Does Serum Vitamin D Level Affect COVID-19 Infection and Its Severity?-A Case-Control Study, J Am Coll Nutr, doi:10.1080/07315724.2020.1826005

Zhu, Wei, Niu, The novel coronavirus outbreak in Wuhan, China, Global Health Research and Policy, doi:10.1186/s41256-020-00135-6

{ 'indexed': {'date-parts': [[2022, 2, 17]], 'date-time': '2022-02-17T23:11:08Z', 'timestamp': 1645139468394}, 'reference-count': 29, 'publisher': 'ARAN Ediciones', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'short-container-title': ['Nutr Hosp'], 'published-print': {'date-parts': [[2022]]}, 'DOI': '10.20960/nh.03731', 'type': 'journal-article', 'created': {'date-parts': [[2022, 2, 16]], 'date-time': '2022-02-16T15:36:50Z', 'timestamp': 1645025810000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': ['Severe COVID-19 patients have severe vitamin D deficiency in Northeast Mexico'], 'prefix': '10.20960', 'author': [ { 'given': 'Manuel Enrique', 'family': 'de la O-Cavazos', 'sequence': 'first', 'affiliation': []}, { 'given': 'Edgar Paolo', 'family': 'Rodríguez Vidales', 'sequence': 'additional', 'affiliation': []}, {'given': 'Denise', 'family': 'Garza Carrillo', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Ana María', 'family': 'Salinas Martínez', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Olivia Abigail', 'family': 'Robles Rodríguez', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Roberto', 'family': 'Montes de Oca Luna', 'sequence': 'additional', 'affiliation': []}, {'given': 'Consuelo', 'family': 'Treviño Garza', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Alma Rosa', 'family': 'Marroquín Escamilla', 'sequence': 'additional', 'affiliation': []}], 'member': '8588', 'container-title': ['Nutrición Hospitalaria'], 'original-title': [], 'deposited': { 'date-parts': [[2022, 2, 16]], 'date-time': '2022-02-16T15:36:58Z', 'timestamp': 1645025818000}, 'score': 1, 'resource': {'primary': {'URL': None}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022]]}, 'references-count': 29, 'URL': 'http://dx.doi.org/10.20960/nh.03731', 'relation': {}, 'ISSN': ['1699-5198', '0212-1611'], 'issn-type': [{'value': '1699-5198', 'type': 'electronic'}, {'value': '0212-1611', 'type': 'print'}], 'subject': ['Nutrition and Dietetics', 'Medicine (miscellaneous)'], 'published': {'date-parts': [[2022]]}}

Download Image

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0